Lexicon Pharmaceuticals

Youtube Subscribe

Open: 1.8 Close: 1.87 Change: 0.07

Our AI found some flaws in Lexicon Pharmaceuticals.

The game is changing. There is a new strategy to evaluate Lexicon Pharmaceuticals fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Lexicon Pharmaceuticals are: Lexicon, Pharmaceuticals, stock, share, LXRX, Inc, Friday, …

Concept Map

Semantic Network

Stock Summary

Lexicon Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the.

Today's Summary

Lexicon Pharmaceuticals Inc (LXRX) stock has fallen -7.03% while the S&P 500 has risen 0.59% as of 10:02 AM on Friday, Aug 4. CEO Lonnel Coats bought 40,000 shares of Lexicon pharmaceuticals stock in a transaction on June 22.

Today's News

Lexicon Pharmaceuticals Inc (LXRX) stock has fallen -7.03% while the S&P 500 has risen 0.59% as of 10:02 AM on Friday, Aug 4. Lexicon pharmaceuticals inc (lxrx) stock is most popular amongst private equity firms who own 49%, while individual investors hold 25%. Lexicon Pharmaceuticals (NASDAQ: LXRX) reported quarterly losses of $0.22 per share which missed the analyst consensus estimate of $1.17 by 29.41 percent. Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Lexicon. Inpefa (sotagliflozin) just became the first FDA-approved dual SGLT2 / SGL T1 inhibitor for treating heart failure. Lexicon Pharmaceuticals is recruiting for a Purchasing Coordinator. PC Support Manager income Estimation: $112,482 - $144,685. CEO Lonnel Coats bought 40,000 shares of Lexicon Pharmaceuticals stock in a transaction dated Thursday, June 22nd. Hedge funds and other institutional investors have recently bought and sold shares of the stock. Shares of NASDAQ:LXRX opened at $1.87 on Friday. Lexicon Pharmaceuticals, Inc. (LXRX) Dividend History, Dates & Yield - Stock Analysis. Lexicon pharmaceuticals, inc. (lxrx) (LxRX): CEO Lonnel Coats purchased 40,000 shares of the businesss stock in a transaction on Thursday, June 22nd. Citigroup boosted their price objective on shares of Lexicon. from $6.00. Analyst Nate Evangel exponential Archer morphed workoutHy Sam watt

Stock Profile

"Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas."

Keywords

This document will help you to evaluate Lexicon Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Lexicon Pharmaceuticals are: Lexicon, Pharmaceuticals, stock, share, LXRX, Inc, Friday, and the most common words in the summary are: lexicon, pharmaceutical, follow, stock, nasdaq, market, inc, . One of the sentences in the summary was: CEO Lonnel Coats bought 40,000 shares of Lexicon pharmaceuticals stock in a transaction on June 22.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #lexicon #pharmaceutical #follow #stock #nasdaq #market #inc.

Read more →

Youtube Subscribe

---